Pediatrics

389

LikeLikedUnlike

31-36 of 36

MinuteCE®
The Future of ADH1 - Looking at Emergent Treatments
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 credits 4 episodes
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
MinuteCE®
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits
CASR and ADH1: Integrating Biology and Genetic Screening
MinuteCE®
CASR and ADH1: Integrating Biology and Genetic Screening
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits
Therapeutic Options for ADH1 and Hypoparathyroidism
MinuteCE®
Therapeutic Options for ADH1 and Hypoparathyroidism
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits
Emerging Therapeutics in ADH1: Progress in Precision Medicine
MinuteCE®
Emerging Therapeutics in ADH1: Progress in Precision Medicine
- Michael A. Levine, MD, FAAP, MACE, FACP
  Peer
- B. Michelle Schweiger, DO, MPH
  Peer
1.00 program credits
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
CME/CE
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
- Danielle Becker, MD, MS, FAES
  Peer
- Ahmed Abdelmoity, MD
  Peer
- Deborah Holder, MD
  Peer
- John Stern, MD
  Peer
advertisement